Lobe Sciences Hopes To Move Novel Psilocin Drug Compounds Quickly Through The FDA Funnel Nov 22, 2022
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with… Feb 17, 2022
Psygen Receives Dealer’s Licence To Become Canada’s First Dedicated Psychedelics Manufacturing Facility Jan 18, 2022
Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin Oct 27, 2021
Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety and Shorter Duration of Action… Aug 10, 2021
